Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Molecular mutagenesis of ppGpp: turning a RelA activator into an inhibitor

J. Beljantseva, P. Kudrin, S. Jimmy, M. Ehn, R. Pohl, V. Varik, Y. Tozawa, V. Shingler, T. Tenson, D. Rejman, V. Hauryliuk,

. 2017 ; 7 (-) : 41839. [pub] 20170203

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

The alarmone nucleotide (p)ppGpp is a key regulator of bacterial metabolism, growth, stress tolerance and virulence, making (p)ppGpp-mediated signaling a promising target for development of antibacterials. Although ppGpp itself is an activator of the ribosome-associated ppGpp synthetase RelA, several ppGpp mimics have been developed as RelA inhibitors. However promising, the currently available ppGpp mimics are relatively inefficient, with IC50 in the sub-mM range. In an attempt to identify a potent and specific inhibitor of RelA capable of abrogating (p)ppGpp production in live bacterial cells, we have tested a targeted nucleotide library using a biochemical test system comprised of purified Escherichia coli components. While none of the compounds fulfilled this aim, the screen has yielded several potentially useful molecular tools for biochemical and structural work.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19001324
003      
CZ-PrNML
005      
20190108130322.0
007      
ta
008      
190107s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/srep41839 $2 doi
035    __
$a (PubMed)28157202
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Beljantseva, Jelena $u University of Tartu, Institute of Technology, Nooruse 1, 50411 Tartu, Estonia.
245    10
$a Molecular mutagenesis of ppGpp: turning a RelA activator into an inhibitor / $c J. Beljantseva, P. Kudrin, S. Jimmy, M. Ehn, R. Pohl, V. Varik, Y. Tozawa, V. Shingler, T. Tenson, D. Rejman, V. Hauryliuk,
520    9_
$a The alarmone nucleotide (p)ppGpp is a key regulator of bacterial metabolism, growth, stress tolerance and virulence, making (p)ppGpp-mediated signaling a promising target for development of antibacterials. Although ppGpp itself is an activator of the ribosome-associated ppGpp synthetase RelA, several ppGpp mimics have been developed as RelA inhibitors. However promising, the currently available ppGpp mimics are relatively inefficient, with IC50 in the sub-mM range. In an attempt to identify a potent and specific inhibitor of RelA capable of abrogating (p)ppGpp production in live bacterial cells, we have tested a targeted nucleotide library using a biochemical test system comprised of purified Escherichia coli components. While none of the compounds fulfilled this aim, the screen has yielded several potentially useful molecular tools for biochemical and structural work.
650    _2
$a Escherichia coli $x genetika $x metabolismus $7 D004926
650    _2
$a guanosintetrafosfát $x metabolismus $x farmakologie $7 D006159
650    _2
$a ligasy $x antagonisté a inhibitory $x genetika $x metabolismus $7 D008025
650    12
$a mutageneze $7 D016296
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kudrin, Pavel $u University of Tartu, Institute of Technology, Nooruse 1, 50411 Tartu, Estonia.
700    1_
$a Jimmy, Steffi $u Department of Molecular Biology, Umeå University, Building 6K, 6L University Hospital Area, SE-901 87 Umeå, Sweden. Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University, Building 6K and 6L, University Hospital Area, SE-901 87 Umeå, Sweden.
700    1_
$a Ehn, Marcel $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences v.v.i., Flemingovo nám. 2, 166 10 Prague 6, Czech Republic.
700    1_
$a Pohl, Radek $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences v.v.i., Flemingovo nám. 2, 166 10 Prague 6, Czech Republic.
700    1_
$a Varik, Vallo $u University of Tartu, Institute of Technology, Nooruse 1, 50411 Tartu, Estonia. Department of Molecular Biology, Umeå University, Building 6K, 6L University Hospital Area, SE-901 87 Umeå, Sweden. Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University, Building 6K and 6L, University Hospital Area, SE-901 87 Umeå, Sweden.
700    1_
$a Tozawa, Yuzuru $u Graduate School of Science and Engineering, Saitama University, 255 Shimo-Okubo, Sakura-ku, Saitama, Saitama 338-8570, Japan.
700    1_
$a Shingler, Victoria $u Department of Molecular Biology, Umeå University, Building 6K, 6L University Hospital Area, SE-901 87 Umeå, Sweden.
700    1_
$a Tenson, Tanel $u University of Tartu, Institute of Technology, Nooruse 1, 50411 Tartu, Estonia.
700    1_
$a Rejman, Dominik $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences v.v.i., Flemingovo nám. 2, 166 10 Prague 6, Czech Republic.
700    1_
$a Hauryliuk, Vasili $u University of Tartu, Institute of Technology, Nooruse 1, 50411 Tartu, Estonia. Department of Molecular Biology, Umeå University, Building 6K, 6L University Hospital Area, SE-901 87 Umeå, Sweden. Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University, Building 6K and 6L, University Hospital Area, SE-901 87 Umeå, Sweden.
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 7, č. - (2017), s. 41839
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28157202 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190107 $b ABA008
991    __
$a 20190108130522 $b ABA008
999    __
$a ok $b bmc $g 1365208 $s 1039447
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 7 $c - $d 41839 $e 20170203 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20190107

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...